1ICSH.Guidelines for the evaluation of blood cell analysers including those used for differential leucocyte and reticulocyte counting and cell marker applications[J].Clin Lab Haemat,1994,16:157-174.
2CLSI.Evaluation of Precision Performance of Quantitative Measurement Methods;Approved Guideline-Second Edition(EP5-A2).940 West Road,Suite 1400,Wayne,PA 19087-1898 USA,2004.
3CLSI.Method Comparison and Bias Estimation Using Patient Samples;Approved Guideline-Second Edition.Document EP9-A2.940 West Valley Road,Suite 1400,Wayne,PA 19087-1898 USA,2002.
4CLSI.Reference Leukocyte Differential Count(Proportional) and Evaluaton of Instrumental Methods;Approved Standard.Document H20-A.940 West Valley Road,Suite 1400,Wayne,PA 19087-1898 USA,1992.
5CISI.Preliminary Evaluation of Quantitative Clinical Laboratory Methods;Approved Guideline-Second Edition.Document EP10-A2.940 West Valley Road,Suite 1400,Wayne,PA 19087-1898 USA,2002.
6CLSI.Assessment of the Clinical Accuracy of Laboratory Tests Using Receiver Operating Characteristic (ROC) Plots;Approved Guideline.Document GP 20-A.940 West Valley Road,Suite 1400,Wayne,PA 19087-1898 USA,1995.
7Center for Devices and Radiological Health(CDRH),U.S.Department of Food and Drug Administration(FDA).Class Ⅱ Special Controls Guidance Document:Premarket Notification for Automated Differential Cell Counters for Immature of Abnormal Blood Cells:Final Guidance for Industry and FDA.2001.
